Cite
HARVARD Citation
Jeannot, V. et al. (n.d.). The PI3K/AKT pathway promotes gefitinib resistance in mutant KRAS lung adenocarcinoma by a deacetylase‐dependent mechanism. International journal of cancer. 134 (11), pp. 2560-2571. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Jeannot, V. et al. (n.d.). The PI3K/AKT pathway promotes gefitinib resistance in mutant KRAS lung adenocarcinoma by a deacetylase‐dependent mechanism. International journal of cancer. 134 (11), pp. 2560-2571. [Online].